Bruker (BRKR) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.81% |
| Dec 31, 2025 | -31.86% |
| Sep 30, 2025 | -24.18% |
| Jun 30, 2025 | -56.28% |
| Mar 31, 2025 | 13.21% |
| Dec 31, 2024 | -12.79% |
| Sep 30, 2024 | -7.84% |
| Jun 30, 2024 | -12.87% |
| Mar 31, 2024 | 13.27% |
| Dec 31, 2023 | 15.75% |
| Sep 30, 2023 | 12.76% |
| Jun 30, 2023 | 12.35% |
| Mar 31, 2023 | 24.39% |
| Dec 31, 2022 | 8.67% |
| Sep 30, 2022 | 22.23% |
| Jun 30, 2022 | 18.17% |
| Mar 31, 2022 | 24.36% |
| Dec 31, 2021 | 8.82% |
| Sep 30, 2021 | 20.40% |
| Jun 30, 2021 | 35.06% |
| Mar 31, 2021 | 24.60% |
| Dec 31, 2020 | 46.29% |
| Sep 30, 2020 | 26.12% |
| Jun 30, 2020 | 4.27% |
| Mar 31, 2020 | 2.90% |
| Dec 31, 2019 | 20.65% |
| Sep 30, 2019 | 56.02% |
| Jun 30, 2019 | 7.54% |
| Mar 31, 2019 | 19.59% |
| Dec 31, 2018 | 16.53% |
| Sep 30, 2018 | 19.53% |
| Jun 30, 2018 | 3.94% |
| Mar 31, 2018 | 33.96% |
| Dec 31, 2017 | 13.96% |
| Sep 30, 2017 | -3.82% |
| Jun 30, 2017 | 9.37% |
| Mar 31, 2017 | 3.27% |
| Dec 31, 2016 | 2.61% |
| Sep 30, 2016 | 1.76% |
| Jun 30, 2016 | -11.61% |
| Mar 31, 2016 | 6.53% |
| Dec 31, 2015 | 23.49% |
| Sep 30, 2015 | -9.18% |
| Jun 30, 2015 | -5.50% |
| Mar 31, 2015 | -15.15% |